Evidence map›Paper›PMID 28914817›Full record

ArticleViruses2017

LEDGF/p75 Deficiency Increases Deletions at the HIV-1 cDNA Ends.

Murilo T D Bueno, Daniel Reyes, Manuel Llano

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Murilo T D BuenoDepartment of Biological Sciences, University of Texas at El Paso. El Paso, TX 79968, USA. murilotdb@outlook.com.
Daniel ReyesDepartment of Biological Sciences, University of Texas at El Paso. El Paso, TX 79968, USA. dsr8721@gmail.com.
Manuel LlanoDepartment of Biological Sciences, University of Texas at El Paso. El Paso, TX 79968, USA. mllano@utep.edu.
The University of Texas at El Paso · US

Funding

Role of PARP-1 in HIV-1 latent infectionSC1GM115240 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI LLANO, MANUEL · 2016 to 2019
$1.5M
NIGMS NIH HHS SC1 GM115240
6 · The paper itself

Abstract

Processing of unintegrated linear HIV-1 cDNA by the host DNA repair system results in its degradation and/or circularization. As a consequence, deficient viral cDNA integration generally leads to an increase in the levels of HIV-1 cDNA circles containing one or two long terminal repeats (LTRs). Intriguingly, impaired HIV-1 integration in LEDGF/p75-deficient cells does not result in a correspondent increase in viral cDNA circles. We postulate that increased degradation of unintegrated linear viral cDNA in cells lacking the lens epithelium-derived growth factor (LEDGF/p75) account for this inconsistency. To evaluate this hypothesis, we characterized the nucleotide sequence spanning 2-LTR junctions isolated from LEDGF/p75-deficient and control cells. LEDGF/p75 deficiency resulted in a significant increase in the frequency of 2-LTRs harboring large deletions. Of note, these deletions were dependent on the 3' processing activity of integrase and were not originated by aberrant reverse transcription. Our findings suggest a novel role of LEDGF/p75 in protecting the unintegrated 3' processed linear HIV-1 cDNA from exonucleolytic degradation.

Indexed as

Sequence DeletionCD4-Positive T-LymphocytesCell LineDNA, ComplementaryDNA, ViralHIV-1HumansIntercellular Signaling Peptides and ProteinsProtein BindingTerminal Repeat SequencesVirus IntegrationDNA, ComplementaryDNA, ViralIntercellular Signaling Peptides and Proteinslens epithelium-derived growth factor2-LTR circlesHIV-1LEDGF/p75unintegrated HIV-1 cDNA

Identifiers

PMID28914817
PMCPMC5618025
OpenAlexW2756179428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.